Allergic-Specific Immunotherapy Using Injectable In Situ Crosslinked Hyaluronic Acid Hydrogels Ameliorates Allergic Response in Murine Allergic Rhinitis Model

被引:0
|
作者
Lee, Hyun Jong [1 ]
Kim, Ji An [2 ]
Lee, Yerin [1 ]
Lim, Saebin [1 ]
Chun, Yoon Hong [2 ]
机构
[1] Gachon Univ, Sch Chem Biol & Battery Engn, Seongnam, South Korea
[2] Catholic Univ Korea, Dept Pediat, Incheon St Marys Hosp, Coll Med, 56 Dongsu Ro, Incheon 21431, South Korea
基金
新加坡国家研究基金会;
关键词
Allergen immunotherapy; allergic rhinitis; house dust mites; hyaluronic acid; hydrogels; RHINOCONJUNCTIVITIS;
D O I
10.4168/aair.2025.17.1.60
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose: We present a convenient and safe allergen-specific immunotherapy using injectable hyaluronic acid (HA) hydrogel containing house dust mite (HDM) crosslinked via visible- light-induced thiol-ene reaction. Methods: We developed 2 types of HDM-containing HA hydrogels, namely thiolated HA (SH-HA) + methacrylated HA (MA-HA) (Gel-1) and 4-arm poly (ethylene glycol) (PEG)-SH + MA-HA (Gel-2). The immunotherapeutic effect of the hydrogels was tested using a murine model of allergic rhinitis. Sensitized mice received 3 subcutaneous injections of the HDM extract (subcutaneous immunotherapy [SCIT] group) or phosphate buffer saline (negative and positive control) at 2-day intervals. Mice in the HA hydrogel immunotherapy groups received one subcutaneous injection of each HA hydrogel precursor solution that formed hydrogel by transmitting blue light through the skin. All except the negative control received HDM extract intranasally for 5 days. Nasal symptoms, ear swelling, eosinophil count, antibody levels, and histopathology of the nasal mucosa were analyzed. Results: All HDM-containing immunotherapy groups exhibited reduced nasal symptoms, ear swelling, and eosinophil count in nasopharyngeal lavage compared to the positive control group. Eosinophils, mast cells, and goblet cells in the nasal mucosa decreased in all treatment groups compared to the positive control group. The serum levels of HDM-specific immunoglobulin G (IgG)1 increased in all treatment groups; however, IgG2a levels increased only in the SCIT and Gel-2 groups. Interleukin (IL)-4, 13, and 17 decreased in all treatment groups compared to those in the positive control group, whereas IL-10level increased only in the SCIT and Gel-2 groups. SCIT and Gel-2 treatment showed similar capability to induce regulatory T cells. Conclusions: Injectable HA hydrogel containing HDM reduced allergic symptoms and induced tolerance in a murine model of allergic rhinitis.
引用
收藏
页码:60 / 76
页数:17
相关论文
共 50 条
  • [31] Detection of antigen-specific IgE and IgG following intranasal sensitization of mice. Development of a murine model of allergic rhinitis
    McCusker, C
    Hamid, QA
    Mazer, B
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S364 - S364
  • [32] Fel d 1 Peptide Immunotherapy Ameliorates Both Cat and Ovalbumin Responses, in a Dual Allergen Murine Model of Allergic Airways Disease
    Moldaver, Daniel M.
    Bharhani, Mantej S.
    Rudulier, Christopher D.
    Wattie, Jennifer
    Inman, Mark D.
    Larche, Mark
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB64 - AB64
  • [33] Oral Immunotherapy with a Phosphorylated Hypoallergenic Allergen Ameliorates Allergic Responses More Effectively Than Intact Allergen in a Murine Model of Buckwheat Allergy
    Katayama, Shigeru
    Yamaguchi, Daiki
    Suzuki, Yuta
    Al Athamneh, Ahmad M.
    Mitani, Takakazu
    Satoh, Rie
    Teshima, Reiko
    Mine, Yoshinori
    Nakamura, Soichiro
    MOLECULAR NUTRITION & FOOD RESEARCH, 2018, 62 (21)
  • [34] In Vivo and In Vitro Studies of Th17 Response to Specific Immunotherapy in House Dust Mite-Induced Allergic Rhinitis Patients
    Li, Chun Wei
    Lu, Han Gui
    Chen, De Hua
    Lin, Zhi Bin
    Wang, De Yun
    Li, Tian Ying
    PLOS ONE, 2014, 9 (03):
  • [35] House dust mite allergen-specific immunotherapy using an adjuvant- and allergoid-based approach in a murine model of allergic asthma
    Heldner, A.
    Alessandrini, F.
    Russkamp, D.
    Heine, S.
    Zissler, U.
    Chaker, A.
    Skinner, M. A.
    Heath, M. D.
    Kramer, M. F.
    Schmidt-Weber, C. B.
    Blank, S.
    ALLERGY, 2020, 75 : 97 - 97
  • [36] α7 nicotinic acetylcholine receptor agonist attenuates allergen-induced immediate nasal response in murine model of allergic rhinitis
    Yamashita, Shuhei
    Miura, Kento
    Matsuura, Anna
    Yamasaki, Norimasa
    Uda, Naoto
    Ogata, Sawako
    Hosomi, Naohisa
    Nakajima, Shotaro
    Kitamura, Noriko
    Gotoh, Minoru
    Mori, Akio
    Kaminuma, Osamu
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2024, 86 (07): : 824 - 827
  • [37] Analysis of the dynamics of clinical indicators in patients with allergic rhinitis with sensitization to pollen and household allergens using combined allergen-specific immunotherapy
    Biletska, S., V
    Dytyatkovska, E. M.
    Nikolaychuk, M. A.
    MEDICNI PERSPEKTIVI, 2021, 26 (04): : 87 - 93
  • [38] Neutralization of interleukin-9 ameliorates symptoms of allergic rhinitis by reducing Th2, Th9, and Th17 responses and increasing the Treg response in a murine model
    Gu, Zhao Wei
    Wang, Yun Xiu
    Cao, Zhi Wei
    ONCOTARGET, 2017, 8 (09) : 14314 - 14324
  • [39] Understanding the dynamics of an endogenous ova specific CD8+T-cell response in a murine model of allergic airway disease
    McNamara, Jeffery Thomas
    Singh, Anurag
    Secor, Eric
    Guernsey, Linda
    Thrall, Roger
    Lefrancois, Leo
    FASEB JOURNAL, 2008, 22
  • [40] Detection at local inflammatory responses and allergen-specific IgG and IgE following intranasal sensitization of mice. Development of a murine model of allergic rhinitis
    McCusker, CT
    Li, XF
    Hamid, QA
    Mazer, BD
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S152 - S152